DDX3X and extranodal nasal NK/T cell lymphoma: Among them, mutations in DDX3X were identified in ~ 20% NKTCL patients, and it has been shown that DDX3X mutations can result in cell-cycle progression and transcriptional activation of the NF-κB pathways [7].